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Abstract
Background: Hesperetin is a bioflavonoid compound, largely used in Chinese
traditional medicine and found plenty in citrus fruits. Hesperetin has beneficial
effects against different diseases. The sperm cryopreservation process is a common
method that is used in infertility laboratories. It has been reported that during the
cryopreservation process, the quality of sperm is significantly reduced.
Objective: To investigate the effect of hesperetin on the quality of human spermatozoa
during the cryopreservation process.
Materials and Methods: In this experimental study, 22 sperm sample of
normozoospermia men who reffered to the infertility department of the Shariati
Hospital (Tehran, Iran) Between October and November 2019 were collect and divided
in to three groups as: 1) fresh, 2) control (frozen-thawed group without treatment), and
3) treatment group as frozen-thawed samples supplemented with 20 µM hesperetin.
Motility, Viability, morphology, Apoptotic-like changes, intracellular H2O2, intracellular
O2−, and lipid peroxidation (LPO) was measured.
Results: Hesperetin treatment during the cryopreservation process of human sperm
significantly improved the viability, motility, and morphology rates of the spermatozoa
after frozen-thawed process in control group (p < 0.01). In addition, it significantly
reduced the reactive oxygen species (ROS) level, LPO level and increased the
percentage of viable sperm cells with intact plasma membrane (p < 0.01) after frozen-
thawed process.
Conclusion: Hesperetin can improve the quality of human sperm and also protect
human sperm against reactive oxygen species, LPO, and apoptosis during the
cryopreservation-thawing process.
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1. Introduction
The cryopreservation process of human
sperm was first introduced in the 1960s
(1). This process is commonly used in
infertility laboratories. This method provides
a possibility for fertility maintenance following
chemotherapy, radiotherapy, or various surgical
procedures. Besides, in cryopreservation
process, screening of donated semen that
is infected by human immunodeficiency
virus (HIV) or hepatitis B virus can be easily
performed (2, 3). Formation of intracellular
ice crystals, osmotic and thermal stresses
during cryopreservation have some adverse
effects on sperm quality, particularly sperm
motility, after the thawing process, which
can damage the cell membrane and leads
to cell death (4, 5). The other important
adverse effects of freezing-thawing process
on sperm are included plasma membrane
and mitochondrial membrane damages (6),
reduction of mitochondrial function (7), DNA
fragmentation (8), and decline in the sperm
motility and survival rates (9). It has been
indicated that during the freezing-thawing
process, the levels of reactive oxygen species
(ROS) increases dramatically (10, 11). Although,
the small concentration of ROS plays an
important role in physiological processes such
as sperm capacitation, acrosome reaction,
maintaining the fertility ability (12, 13) and
fluidity of the membrane (14). However, higher
concentrations of ROS causes major sperm
functional defects, such as decreasing sperm
motility, increasing intracellular enzyme leakage,
and damage to sperm DNA (15). On the other
hand, overproduction of ROS leads to lipid
peroxidation (LPO) which results in reduction
of membrane integrity and induces apoptosis
(14).
Hesperetin (5,7,30-trihydroxy-40-methoxy
flavanone) is a bioflavonoid which is largely
used in Chinese traditional medicine (16). It is
easily found in citrus fruits as hesperidin (its
glycoside form) which is used as a prodrug
(17). Dietary hesperidins are deglycosylated
to hesperetin by intestinal bacteria prior to
absorption (18). Hesperetin has shown to have
several positive effects including antioxidant,
anti-inflammatory, antimicrobial, anti-carcinogenic
and anti-allergic properties (19). Moreover, it is
known to acts as a potent antioxidant agent
against cadmium-induced testicular damages
(20). Moreover, hesperetin has a protective effect
against cardiotoxicity induced by doxorubicin (21).
Hesperetin also can protect the testis tissue from
doxorubicin-induced testicular toxicity (22) and
reduced the risk of testicular damages by inhibiting
oxidative stress, apoptosis, and inflammation in
diabetic rats (23). Hesperetin can be used as a
chemopreventive agent against DMH-induced
colon cancer (24).
To the best of our knowledge, no study
has ever evaluated the effect of hesperetin on
mammalian sperm, especially human, therefore
the current study aimed at evaluating the
protective effects of hesperetin on the quality
of human sperm, apoptosis rate, LPO, and
oxidative stress levels during human semen
cryopreservation.
2. Materials and Methods
2.1. Sample collection
Sperm samples from 22 male donors from
the infertility department of the Shariati Hospital
(Tehran, Iran) Between October and November
2019, whose fertility evaluated using the standard
parameters of the semen (concentration, viability,
motility, and morphology) according to the World
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Health Organization (WHO, 2010 guidelines) had
been proven, were collected via masturbation
inside the sterile containers. Donors were asked
to have at least 72 hr of sexual rest. Following
the 30-min liquefaction at 37°C and 5% CO2, the
semen was evaluated according to the WHO
guidelines. To prevent false results, men with the
history of chronic illnesses, endocrine disorders,
varicocele disease, cigarettes smoking, as well
as history of drug use such as vitamins and
antioxidants (selenium and zinc) were excluded
from the study. Table I presents the characteristics
of semen samples from the participant. In the
current work, three experimental groups were
considered (each semen sample was divided into
three groups): First group (fresh group); Second
group, frozen-thawed group without treatment
with hesperetin (control group); and Third group,
frozen-thawed samples were supplemented
with 20 µM hesperetin (treatment group), in
this group 20 µM hesperetin was added to
the semen samples befor freezing-thawing
process. The effective dose of hesperetin was
determined (20 µM) by evaluating different
concentrations of it (data is not published). All
of the samples were analyzed before and also
after frozen-thawed process of semen. The
viability rate was evaluated by eosin/nigrosin
staining, motility rate by computer-assisted sperm
analyzer (CASA), the normal morphology by
Diff-Quick staining, LPO by Malondialdehyde
(MDA) Assay Kit, ROS levels (O2− and H2O2) by
DCFH-DA and DHE Kits, and the occurrence
of apoptosis-like changes by Y0-PRO-1/PI
Assay.
2.2. Cryopreservation and thawing
process
Following the assessment of sperm parameters,
LPO, ROS, and apoptosis rates in fresh samples,
the remaining volume was divided into two
groups; the control group and the treatment
group. Both groups were incubated for 1 hr at
37°C. Freezing process was performed according
to the following steps: sperm freezing medium
(Vitrolife, Goteborg, Sweden) by drop-wise on
semen samples in a proportion of 1:1. After the
equilibrium, at room temperature for 10 min, the
cryotubes were placed in liquid nitrogen vapor
(10-15 cm above the liquid nitrogen level at -
80°C) for 15 min followed by plunging cryotubes
in liquid nitrogen (-196) for 2 wk. Thawing process
of semen samples was performed according to
the following steps: the samples were removed
from the liquid nitrogen and placed at room
temperature for 15 min. The freezing medium was
removed by adding the equal volume of Ham’s
F10 medium (Life global, Guelph, ON, Canada)
containing 5% HAS to the semen plus freezing
medium and centrifuged at 200× g for 5 min.
Then, the pellet was resuspended in the same
medium. Sperm parameters as well as LPO, ROS,
and apoptosis rates were evaluated in post-thawed
samples.
2.3. Evaluation of ROS levels
The ROS level was measured in all three
groups; fresh, control, and treatment groups
using 2’, 7’-dichlorofluorescin diacetate (DCFH-
DA; sigma) for determining intracellular H2O2
and dihydroethidium (DHE; sigma) for determining
intracellular O2−. Samples were incubated with
DCFH-DA (25 µM) and DHE (1.25 µ) for 40 and
20 min in darkness, respectively (25, 26). DCFH-
DA emitted a green fluorescent color that was
evaluated at a wavelength between 530 and
500 nm (in the FL-1 channel). The DHE emitted
a red fluorescent color that was evaluated at
a wavelength between 590 and 700 nm (in
the FL-2 channel) by flow cytometer FACScan
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(Becton Dickinson, San Jose, CA, USA) (25,
26).
2.4. Evaluation of apoptosis-like
changes
The integrity of the membrane in three
groups was assayed with a double-chain yo-
pro-1 and propidium iodide with the Vybrant
Apoptosis Assay Kit (Invitrogen, Carlsbad, CA,
USA). In brief, after washing with PBS, PI (50
µg/ml) and yo-pro-1 (10 µM) were added to
1 ml of sperm suspension and incubated for
25 min at 25°C (26). Samples were evaluated
using green fluorescent color for yo-pro-1
(apoptotic spermatozoa) in the FL-1channel (i.e.,
530/30 band pass) and with red fluorescent
color for PI (necrotic spermatozoa) in the FL-
3 (i.e., 610/20 band pass) by flow cytometer
FACScan (Becton Dickinson, San Jose, CA,
USA). In this assay, four different spermatozoa
populations can be recognized; viable
spermatozoa (Yo-pro-1-/PI-), necrotic spermatozoa
(Yo-pro-1-/PI+), apoptotic spermatozoa (Yo-
pro-1+/PI-), and dead spermatozoa (Yo-pro-
1+/PI+).
2.5. Assessment of sperm viability
Eosin/nigrosin staining was used to determine
the survival rate of sperms (27). This staining
method was performed by mixing 20 µL semen
with 20 µL of 1% eosin (w/v). Then, 20 µL of nigrosin
(10% w/v) was added to this mixture. Sperm smear
was prepared on a slide and then air dried. The
sperm count was measured by observing with
a light microscopy (Olympus microscope CH3O
Tokyo japan) at ×1000 magnification. While the
white sperm were considered as a live sperm,
the colored ones (pink or red in the head
area) were considered as dead. At least 200
sperm were evaluated for calculating the viability
rates.
2.6. Assessment of sperm motility rate
The parameters of motility are determined using
a CASA (28). In this experiment, sperm motility
was divided into four grade: (a) fast progressive,
(b) slow progressive, (c) non-progressive, and (d)
immotile (WHO guideline, 2010). In each group,
each sample was taken at 10 μm and filled
in the Makler chamber and then CASA was
evaluated. The images were analyzed in five
fields for each sample and the images were
taken using the software video TesT sperm
3.1.
2.7. Assessment of sperm normal
morphology
The sperm morphology was determined by
using Diff-Quick rapid sperm staining kit (Dayan
Zist Azma Co.). At least 200 dyed sperm per
each sample were counted using light microscopy
(Olympus microscope CH3O Tokyo japan) at
×1000 magnification. The morphological criteria
were evaluated according to the WHO guideline
(29).
2.8. Measurement of LPO level
The level of LPO was determined by the
reaction of Thiobarbiuric Acid (TBA) with
MDA using the MDA Assay kit (Zellbio GmbH,
Deutschland) according to manufacturer’s
protocol. After adding the reagents to the
samples, the mixture was heated for 1 hr in
boiling water bath (pink color formation). Then,
the pink-colored supernatant was moved into the
microplate and the absorbance was read at 535
nm.
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Table I. Mean ± SEM percentage of total motility, progressive motility, normal morphology, and sperm concentration of sperm
samples of donors
Sperm parameters Mean ± SEM
*Concentration (×106) 81.63 ± 12.62
**Total motility 70.13 ± 3.28
**Progressive motility 60.63 ± 3.05
**Normal morphology 9.56 ± 1.01
*Data presented as n (concentration); **Data presented as %
2.9. Ethical considerations
All patients participated in this experimental
study with knowledge and consent. This
study was approved by the Ethics Committee
of AJA University of Medical Sciences, Iran
(IR.AJAUMS.REC.1398.243).
2.10. Statistical analysis
Data were analyzed using the SPSS (Statistical
Package for the Social Sciences, version 22,
SPSS Inc, Chicago, Illinois, USA). To indicate the
differences between all experimental groups, one
analysis of variance (one-way ANOVA) was used,
followed by Tukey’s post hoc test. The data were
analyzed at a 95% confidence interval, and the
level of significance was set at p < 0.05.
3. Results
3.1. Effect of hesperetin on sperm
viability
By investigating the effect of hesperetin on
the viability of sperm after the freezing-thawing
process, we found that in the control group
compared to the fresh group, the sperm viability
rate decreased significantly (Table II). In addition,
the viability analysis of semen samples after
freezing-thawing process showed that in the
tatment group, the excessive death of sperm
decreased significantly compared to the control
group (Table II, Figure 1).
3.2. Effect of hesperetin on sperm
motility
The outcomes of the motility analysis
demonstrated that the amount of progressive
motility and total motility in the control group
were reduced significantly compared to the fresh
group (Table II). However, in the treatment group,
hesperetin was able to prevent the reduction of
progressive motility and total motility compared
to the control group (Table II, Figure 2). Also,
after the freezing-thawing process, the sperm
velocity parameters including VSL, VAP, and VCL
were significantly (Table II) reduced compared to
the fresh group. While in the treatment group,
hesperetin was able to increase these parameters
compared to the control group (Table II, Table III).
3.3. Effect of hesperetin on sperm
morphology
By examining the abnormalities of the head,
midpiece, and tail of sperm, we found that the
percentage of sperm with normal morphology in
the control group was significantly lower than the
fresh group (Table II). However, in the treatment
group, hesperetin was able to reduce the rate of
sperm morphological abnormalities in comparison
to the control group (Table II, Figure 3).
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3.4. Effect of hesperetin on the level of
ROS
As indicated in Figure 4, the average
fluorescence intensity of DCFH-DA and DHE in the
control group increased significantly compared to
the fresh group (Table II). Whereas, in the treatment
group, hesperetin could significantly prevent the
rising of the DCFH-DA and DHE in comparison to
the control group (Table II).
3.5. Effects of hesperetin on
apoptotic-like change
The percentage of sperm cells that underwent
apoptotic-like changes increased significantly in
the control group compared to the fresh group
following the cryopreservation process (Table II).
However, in the treatment group, the amounts of
these cells were significantly decreased compared
to the control group (Table II, Figure 5).
3.6. Effects of hesperetin on LPO of
spermatozoa membranes
As indicated in Figure 6, in the control group,
cryopreservation increased significantly the
rate of LPO of the spermatozoa membrane in
comparison to the fresh group (Table II). While,
in the treatment group, the amount of LPO of
the spermatozoa membrane were significantly
decreased compared to the control group (Table
II, Figure 6).
Table II. Comparison all of the tests in three groups: fresh, control, and treatment groups
Tests Control group compared to
the fresh group
P-Value Treatment group compared to
the control group
P-Value
Viability 47.70 ± 2.70 vs 82.70 ± 5.66 p ≤ 0.001 61.84 ±5.88 vs 47.70 ± 6.32 p ≤ 0.001
Progressive motility 25.50 ± 4.59 vs 60.63 ± 3.58 p ≤ 0.001 35.25 ± 6.31 vs 25.50 ± 4.59 p = 0.021
Total motility 30.38 ± 4.74 vs 70.13 ± 9.28 p ≤ 0.001 42.38 ± 9.24 vs 30.38 ± 4.74 p = 0.018
VSL,VAP,VCL parameters - p ≤ 0.01 - p ≤ 0.01
Morphology 2.87 ± 0.95 vs 9.56 ± 1.01 p ≤ 0.001 6.0. ± 0.72 vs 2.87 ± 0.95 p ≤ 0.01
DCFH-DA 50.75 ± 2.25 vs 7 ± 2.80 p ≤ 0.001 34.50 ± 3.89 vs 50.75 ± 2.25 p ≤ 0.001
DHE 10.13 ± 1.06 vs 3.81 ± 0.70 p ≤ 0.001 8.32 ± 0.36 vs 10.13 ± 1.06 p ≤ 0.01
Apoptosis 7.15 ± 0.67 vs 3.08 ± 0.74 p ≤ 0.001 4.45 ± 0.58 vs 7.15 ± 0.67 p ≤ 0.001
LPO 11.08 ± 1.76 vs 1.96 ± 0.72 p ≤ 0.001 8.23 ± 1.37 vs 11.08 ± 1.76 p ≤ 0.01
Data presented as Mean ± SD. One-way analysis of variance (ANOVA) followed by Tukey’s post test, DCFH-DA: 2’, 7’-
dichlorofluorescin diacetate; DHE: Dihydroethidium; LPO: Lipid peroxidation
Table III. Comparison of human sperm velocity parameters in three groups: fresh, control, and treatment groups
Group VCL (μm/sec) VSL (μm/sec) VAP (μm/sec) LIN (%) STR (%) ALH (μm) WOB (%)
Fresh 95.25 ± 10.34𝑎 55.25 ± 13.71𝑎 57.38 ± 11.36𝑎 58.75 ± 14.58 95.38 ± 05.99 1.47 ± 0.78𝑎 61 ± 12.02
Control 39.75 ± 6.69𝑏 18.75 ± 7.63𝑏 20.75 ± 6.81𝑏 47.50 ± 19.08 87.50 ± 18.12 0.85 ± 0.21𝑏 52 ± 13.30
Treatment 75.13 ± 10.30 𝑐 44.25 ± 8.08𝑎 46.75 ± 6.79𝑎 57.70 ± 09.98 94.25 ± 08.66 0.91 ± 0.18𝑎𝑏 60 ± 7.54
P-values ≤ 0.01 ≤ 0.01 ≤ 0.01 > 0.23 > 0.40 ≤ 0.01 > 0.11
Data presented asMean± SD. One-way analysis of variance (ANOVA) followed by Tukey’s post test, VCL: Velocity of curvilinear;
VSL: Velocity of straight line; VAP: Velocity of average path; LIN: Linearity = VSL/VCL×100; STR: Straightness = VSL/VAP×100;
ALH: Amplitude lateral head; WOB: Wobble VAP/VCL×100, A different letter in each column shows a significant difference
between the groups at the level of p < 0.01and the same letter shows a non-significant difference between the groups at p >
0.05
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Figure 1. Viability rates in all three groups are indicated by eosin/nigrosin assay staining; fresh, treatment, and control groups
(Mean ± SEM). *** Represent a significant difference between groups at p < 0.001 level.
Figure 2. Progressive motility (a) and total motility (b) in all three groups; fresh, treatment, control groups (Mean ± SEM).
***Represent a significant difference between groups at p < 0.001 level and *Represents a significant difference between groups
at p < 0.05 level. Data were compared by One-way Analysis of Variance (ANOVA) and Tukey’s posttest.
Figure 3. Analysis of normal morphology with Diff-Quick assay in fresh, control, and treatment groups (Mean ± SEM). ***Represent
a significant difference between groups at p < 0.001 level and **Represent a significant difference between groups at p < 0.01
level. Data were compared by One-way Analysis of Variance (ANOVA) and Tukey’s posttest.
Figure 4. Comparison of intracellular H2O2 level (a) and intracellular O2 level (b) in all three experimental groups (Mean ± SEM).
***Represent a significant difference between groups at p < 0.001 level and **Represent a significant difference between groups
at p < 0.01 level. Data were compared by One-way Analysis of Variance (ANOVA) and Tukey’s posttest.
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Figure 5. The average percentage of apoptotic-like sperm cells in fresh, control, and treatment groups (Mean± SEM). ***Represent
a significant difference between groups at p < 0.001 level. Data were compared by One-way Analysis of Variance (ANOVA) and
Tukey’s posttest.
Figure 6. The LPO rate in the spermatozoa membrane in fresh, control, and treatment groups (Mean ± SEM). ***Represent a
significant difference between groups at p < 0.001 level and **Represent a significant difference between groups at p < 0.01 level.
Data were compared by One-way Analysis of Variance (ANOVA) and Tukey’s posttest.
4. Discussion
In the current work, we have shown that
treatment of human sperm with 20 µM hesperetin
prior to the cryopreservation process can reduce
the harmful effects of cryopreservation on
spermatozoa and subsequently increase the
fertility rate after the freezing-thawing procedure.
The results of our study showed that hesperetin
improved spermatozoa viability, morphology, and
motility after cryopreservation. Also Hesperetin
can reduce the ROS level, the rate of LPO, and
percentage of like-apoptosis sperm.
Cryopreservation process of sperm is a useful
and effective method for preserving the sperm
of people in infertility conditions (30). Although
cryopreservation has opened the promising
possibility for fertility preservation, this procedure
has several harmful effects on morphology, motility,
and viability of sperm. Also, cryopreservation can
lead to increase in sperm apoptosis rate, ROS
generation, and LPO of the sperm membrane (7, 11,
31, 32).
Apoptosis induction is one of the most complex
and detrimental effects of cryopreservation
on spermatozoa (33). Evidence disclosed that
apoptosis increases during the cryopreservation
process. There are several methods to illustrate
the apoptosis process. One of these methods is
the yo-pro-1 assay which can detect the apoptosis
changes in the sperm membrane (32). This study
showed a significant increase in permeability of
the sperm membrane after the freezing-thawing
process. These results are consistent with the other
investigations that reported the remarkable effects
of cryopreservation on the sperm membranes
(34). Also, the results of our study showed that
hesperetin significantly reduced the percentage
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of apoptotic cells after the freezing process. One
study showed that hesperetin significantly reduced
apoptosis in doxorubicin-induced testicular cells
and almost completely prevented the increase
of oxidative stress (22). Hesperetin can reduce
oxidative stress, inflammation, and apoptosis in
diabetic rats (23). The results of the recent study on
hepatocellular carcinoma cells showed that high
doses of hesperetin (125, 250, and 500 μM) were
used to induce apoptosis by the mitochondrial
pathway (35). The cryopreservation has negative
effects on different membranes existing in
sperm such as acrosomal membrane, plasma
membrane, and mitochondrial membrane (36). In
this context, cryopreservation causes capacitation-
like changes in sperm membrane and also induces
the acrosomal reaction in spermatozoa (37, 38).
Capacitation process and acrosomal reaction
are the two most important changes in sperm
membranes which are physiologically necessary
for successful fertilization (39). Therefore, the
effects of cryopreservation on the performance
of the sperm are similar to the effects of sperm
capacitation, in which both processes increase
the permeability of the sperm membrane and the
amount of ROS production (40).
It has been demonstrated that the level of
antioxidants in the sperm decreases during
cryopreservation (41). Previous studies have shown
that adding antioxidants to the freezing medium
can improve the quality of sperm following a
cryopreservation procedure (31, 42). Accordingly,
we used an antioxidant called hesperetin to reduce
the harmful effects of the freezing-thawing process
on spermatozoa. Hesperetin is a bioflavonoid
which is used as a Chinese traditional medicine
(16). Hesperetin is can be found in citrus fruits
as hesperidin (its glycoside form), which acts as
a prodrug (17). Recently, it has been shown that
hesperetin can reduce the amount of MDA, sperm
head abnormalities, and DNA damage induced
by doxorubicin in rats (22). In another study,
hesperetin reduced the amount of ROS in diabetic
rats (23).
During the freezing-thawing process, the
amount of ROS production increases significantly
(41, 43). Human sperm membranes has a large
amount of unsaturated fatty acids (44). ROS is a
potent oxidant agents for human spermatozoa.
Overproduction of ROS leads to the oxidation
of unsaturated fatty acids, and subsequently
increases the membrane LPO (45, 46). The
results of our study showed that the level of ROS
generation increased during the freezing-thawing
process and 20 μM hesperetin significantly
decreased ROS generation. The results of this
study are consistent with recent studies showing
that hesperetin has potent antioxidant effects (22,
23).
Numerous studies have shown that the freezing-
thawing process of human sperm reduced
significantly the total and progressive motility
(47, 48), which is consistent with our study. The
results of our study also showed that the freezing-
thawing process reduced significantly the sperm
velocity parameters including VCL, VSL, and VAP.
However, in presence of 20 μM hesperetin, these
parameters were significantly increased. The
results of our study are also consistent with the
study by Minaei and colleague who showed that
Trolox, as an antioxidant, has similar effects on
sperm motility (48).
5. Conclusion
Our findings showed that spermatozoa
treatment with 20 μM hesperetin before the
freezing-thawing process has protective effects
against oxidative stress and could reduce
the harmful effects of this process on sperm
quality.
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